Risankizumab 00074-1058
Product NDC
00074-1058- Manufacturer
- Abbvie Inc.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- October 26, 2021
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risankizumab | 150 mg/mL |
Packaging Options(1)
1 mL in 1 SYRINGE (0074-1058-00)